Zomedica (ZOM) Status update summary
Event summary combining transcript, slides, and related documents.
Status update summary
13 Apr, 2026Strategic vision and technology innovation
Focus on advancing animal health through practical innovation and expanding digital capabilities, with technology and AI central to growth and improved clinical outcomes.
Five pillars guide decisions: improving pet care, enhancing pet parent satisfaction, streamlining veterinary workflow, supporting veterinarian cash flow, and increasing clinic profitability.
Investment in connected devices, cloud platforms, and AI to create integrated product experiences and actionable clinical insights.
Market trends and digital transformation
AI in animal health projected to grow from $1.57B in 2024 to $7B by 2033, with pet tech and telehealth markets also expanding rapidly.
Zomedica's digital transformation includes MyZomedica platform, mobile apps, e-commerce, and over-the-air software updates, supporting scalable growth.
Launch of TRUVIEW AI and PIMS integration targeted for Q2 2026 to enhance workflow and data integration.
Financial outlook and operational milestones
Break-even projected at $55M annualized revenue, with profitability targeted by 2027.
Q4 2025 expected to be a record quarter, marking 20 consecutive quarters of year-on-year revenue growth.
Operating leverage expected to increase as revenue grows, with significant capacity available before further investment is needed.
Consumables account for 70-73% of revenue, supporting recurring revenue growth.
Latest events from Zomedica
- Virtual meeting to vote on directors, auditor, executive pay, and by-law changes; board is majority independent.ZOM
Proxy filing14 Apr 2026 - Record revenue growth and strong margins, with new segments and cost controls driving performance.ZOM
Q4 202516 Mar 2026 - Profitability targeted for 2027, with strong R&D and product innovation fueling growth.ZOM
Status update27 Feb 2026 - Innovative veterinary solutions and recurring revenue drive high growth and margin expansion.ZOM
Small-Cap Growth Virtual Investor Conference1 Feb 2026 - Q2 revenue up 2% to $6.1M, but net loss surged on $16M impairment; margin reached 71%.ZOM
Q2 20241 Feb 2026 - Q3 revenue up 10% to $7M, 72% margin, net loss $6.7M, global expansion ongoing.ZOM
Q3 202415 Jan 2026 - Record $27.3M revenue, 70% margin, and strong liquidity set stage for 2025 growth.ZOM
Q4 202419 Dec 2025 - Virtual meeting to elect directors, ratify auditor, and hold say-on-pay vote, with strong governance.ZOM
Proxy Filing2 Dec 2025 - Virtual annual meeting set for June 10; all shareholders urged to vote by June 8.ZOM
Proxy Filing2 Dec 2025